CGG allele size somatic mosaicism and methylation in FMR1 premutation alleles

Dalyir I. Pretto, Guadalupe Mendoza-Morales, Joyce Lo, Ru Cao, Andrew Hadd, Gary J. Latham, Blythe Durbin-Johnson, Randi J Hagerman, Flora Tassone

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Background: Greater than 200 CGG repeats in the 5'UTR of the FMR1 gene lead to epigenetic silencing and lack of the FMR1 protein, causing fragile X Syndrome. Individual carriers of a premutation (PM) allele with 55-200 CGG repeats are typically unmethylated and can present with clinical features defined as FMR1-associated conditions. Methods: Blood samples from 17 male PM carriers were assessed clinically and molecularly by Southern blot, western blot, PCR and QRT-PCR. Blood and brain tissue from an additional 18 PM males were also similarly examined. Continuous outcomes were modelled using linear regression and binary outcomes were modelled using logistic regression. Results: Methylated alleles were detected in different fractions of blood cells in all PM cases (n=17). CGG repeat numbers correlated with percent of methylation and mRNA levels and, especially in the upper PM range, with greater number of clinical involvements. Inter-tissue/intra-tissue somatic instability and differences in percent methylation were observed between blood and fibroblasts (n=4) and also observed between blood and different brain regions in three of the 18 PM cases examined. CGG repeat lengths in lymphocytes remained unchanged over a period of time ranging from 2 to 6 years, three cases for whom multiple samples were available. Conclusions: In addition to CGG size instability, individuals with a PM expanded allele can exhibit methylation and display more clinical features likely due to RNA toxicity and/or FMR1 silencing. The observed association between CGG repeat length and percent of methylation with the severity of the clinical phenotypes underscores the potential value of methylation in affected PM to further understand penetrance, inform diagnosis and expand treatment options.

Original languageEnglish (US)
Pages (from-to)309-318
Number of pages10
JournalJournal of Medical Genetics
Volume51
Issue number5
DOIs
StatePublished - 2014

Fingerprint

Mosaicism
Methylation
Alleles
Fragile X Syndrome
Polymerase Chain Reaction
Penetrance
5' Untranslated Regions
Brain
Southern Blotting
Epigenomics
Linear Models
Blood Cells
Fibroblasts
Logistic Models
Western Blotting
Lymphocytes
RNA
Phenotype
Messenger RNA
Genes

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

CGG allele size somatic mosaicism and methylation in FMR1 premutation alleles. / Pretto, Dalyir I.; Mendoza-Morales, Guadalupe; Lo, Joyce; Cao, Ru; Hadd, Andrew; Latham, Gary J.; Durbin-Johnson, Blythe; Hagerman, Randi J; Tassone, Flora.

In: Journal of Medical Genetics, Vol. 51, No. 5, 2014, p. 309-318.

Research output: Contribution to journalArticle

Pretto, DI, Mendoza-Morales, G, Lo, J, Cao, R, Hadd, A, Latham, GJ, Durbin-Johnson, B, Hagerman, RJ & Tassone, F 2014, 'CGG allele size somatic mosaicism and methylation in FMR1 premutation alleles', Journal of Medical Genetics, vol. 51, no. 5, pp. 309-318. https://doi.org/10.1136/jmedgenet-2013-102021
Pretto, Dalyir I. ; Mendoza-Morales, Guadalupe ; Lo, Joyce ; Cao, Ru ; Hadd, Andrew ; Latham, Gary J. ; Durbin-Johnson, Blythe ; Hagerman, Randi J ; Tassone, Flora. / CGG allele size somatic mosaicism and methylation in FMR1 premutation alleles. In: Journal of Medical Genetics. 2014 ; Vol. 51, No. 5. pp. 309-318.
@article{aba4f5bb02c7412ba93cd90e46a5bc79,
title = "CGG allele size somatic mosaicism and methylation in FMR1 premutation alleles",
abstract = "Background: Greater than 200 CGG repeats in the 5'UTR of the FMR1 gene lead to epigenetic silencing and lack of the FMR1 protein, causing fragile X Syndrome. Individual carriers of a premutation (PM) allele with 55-200 CGG repeats are typically unmethylated and can present with clinical features defined as FMR1-associated conditions. Methods: Blood samples from 17 male PM carriers were assessed clinically and molecularly by Southern blot, western blot, PCR and QRT-PCR. Blood and brain tissue from an additional 18 PM males were also similarly examined. Continuous outcomes were modelled using linear regression and binary outcomes were modelled using logistic regression. Results: Methylated alleles were detected in different fractions of blood cells in all PM cases (n=17). CGG repeat numbers correlated with percent of methylation and mRNA levels and, especially in the upper PM range, with greater number of clinical involvements. Inter-tissue/intra-tissue somatic instability and differences in percent methylation were observed between blood and fibroblasts (n=4) and also observed between blood and different brain regions in three of the 18 PM cases examined. CGG repeat lengths in lymphocytes remained unchanged over a period of time ranging from 2 to 6 years, three cases for whom multiple samples were available. Conclusions: In addition to CGG size instability, individuals with a PM expanded allele can exhibit methylation and display more clinical features likely due to RNA toxicity and/or FMR1 silencing. The observed association between CGG repeat length and percent of methylation with the severity of the clinical phenotypes underscores the potential value of methylation in affected PM to further understand penetrance, inform diagnosis and expand treatment options.",
author = "Pretto, {Dalyir I.} and Guadalupe Mendoza-Morales and Joyce Lo and Ru Cao and Andrew Hadd and Latham, {Gary J.} and Blythe Durbin-Johnson and Hagerman, {Randi J} and Flora Tassone",
year = "2014",
doi = "10.1136/jmedgenet-2013-102021",
language = "English (US)",
volume = "51",
pages = "309--318",
journal = "Journal of Medical Genetics",
issn = "0022-2593",
publisher = "BMJ Publishing Group",
number = "5",

}

TY - JOUR

T1 - CGG allele size somatic mosaicism and methylation in FMR1 premutation alleles

AU - Pretto, Dalyir I.

AU - Mendoza-Morales, Guadalupe

AU - Lo, Joyce

AU - Cao, Ru

AU - Hadd, Andrew

AU - Latham, Gary J.

AU - Durbin-Johnson, Blythe

AU - Hagerman, Randi J

AU - Tassone, Flora

PY - 2014

Y1 - 2014

N2 - Background: Greater than 200 CGG repeats in the 5'UTR of the FMR1 gene lead to epigenetic silencing and lack of the FMR1 protein, causing fragile X Syndrome. Individual carriers of a premutation (PM) allele with 55-200 CGG repeats are typically unmethylated and can present with clinical features defined as FMR1-associated conditions. Methods: Blood samples from 17 male PM carriers were assessed clinically and molecularly by Southern blot, western blot, PCR and QRT-PCR. Blood and brain tissue from an additional 18 PM males were also similarly examined. Continuous outcomes were modelled using linear regression and binary outcomes were modelled using logistic regression. Results: Methylated alleles were detected in different fractions of blood cells in all PM cases (n=17). CGG repeat numbers correlated with percent of methylation and mRNA levels and, especially in the upper PM range, with greater number of clinical involvements. Inter-tissue/intra-tissue somatic instability and differences in percent methylation were observed between blood and fibroblasts (n=4) and also observed between blood and different brain regions in three of the 18 PM cases examined. CGG repeat lengths in lymphocytes remained unchanged over a period of time ranging from 2 to 6 years, three cases for whom multiple samples were available. Conclusions: In addition to CGG size instability, individuals with a PM expanded allele can exhibit methylation and display more clinical features likely due to RNA toxicity and/or FMR1 silencing. The observed association between CGG repeat length and percent of methylation with the severity of the clinical phenotypes underscores the potential value of methylation in affected PM to further understand penetrance, inform diagnosis and expand treatment options.

AB - Background: Greater than 200 CGG repeats in the 5'UTR of the FMR1 gene lead to epigenetic silencing and lack of the FMR1 protein, causing fragile X Syndrome. Individual carriers of a premutation (PM) allele with 55-200 CGG repeats are typically unmethylated and can present with clinical features defined as FMR1-associated conditions. Methods: Blood samples from 17 male PM carriers were assessed clinically and molecularly by Southern blot, western blot, PCR and QRT-PCR. Blood and brain tissue from an additional 18 PM males were also similarly examined. Continuous outcomes were modelled using linear regression and binary outcomes were modelled using logistic regression. Results: Methylated alleles were detected in different fractions of blood cells in all PM cases (n=17). CGG repeat numbers correlated with percent of methylation and mRNA levels and, especially in the upper PM range, with greater number of clinical involvements. Inter-tissue/intra-tissue somatic instability and differences in percent methylation were observed between blood and fibroblasts (n=4) and also observed between blood and different brain regions in three of the 18 PM cases examined. CGG repeat lengths in lymphocytes remained unchanged over a period of time ranging from 2 to 6 years, three cases for whom multiple samples were available. Conclusions: In addition to CGG size instability, individuals with a PM expanded allele can exhibit methylation and display more clinical features likely due to RNA toxicity and/or FMR1 silencing. The observed association between CGG repeat length and percent of methylation with the severity of the clinical phenotypes underscores the potential value of methylation in affected PM to further understand penetrance, inform diagnosis and expand treatment options.

UR - http://www.scopus.com/inward/record.url?scp=84899482856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899482856&partnerID=8YFLogxK

U2 - 10.1136/jmedgenet-2013-102021

DO - 10.1136/jmedgenet-2013-102021

M3 - Article

C2 - 24591415

AN - SCOPUS:84899482856

VL - 51

SP - 309

EP - 318

JO - Journal of Medical Genetics

JF - Journal of Medical Genetics

SN - 0022-2593

IS - 5

ER -